Terms: = Thyroid cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Diagnosis
5 results:
1. Divergent Lineage Markers in Anaplastic thyroid Carcinoma.
Mneimneh WS; Asa SL
Am J Surg Pathol; 2024 Feb; 48(2):230-237. PubMed ID: 37972932
[TBL] [Abstract] [Full Text] [Related]
2. [Analysis of Clinicopathologic Features of 9 Cases of
smarca4-deficient Non-small Cell Lung cancer].
Zhao R; Zou Y; Chen H; Chen Y; Liu Y; He M
Zhongguo Fei Ai Za Zhi; 2022 Aug; 25(8):575-582. PubMed ID: 36002194
[TBL] [Abstract] [Full Text] [Related]
3. Cytomorphologic and immunophenotypical analysis of smarca4 (brg1)-deficient non-small cell lung carcinoma.
Ogunbona OB; Lin X; Hornick JL; Lubin DJ; Wang Q; Reid MD; Schneider F; Li D; Shin DM; Shi Q
J Am Soc Cytopathol; 2022; 11(4):183-193. PubMed ID: 35491322
[TBL] [Abstract] [Full Text] [Related]
4. Expanding the Immunophenotype Spectrum of smarca4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression.
Mao R; Liu M; Shu X; Li W; Yan W; Li X
Int J Surg Pathol; 2022 May; 30(3):251-259. PubMed ID: 34633874
[No Abstract] [Full Text] [Related]
5. FDG-PET characteristics of Hürthle cell and follicular adenomas.
Pathak KA; Klonisch T; Nason RW; Leslie WD
Ann Nucl Med; 2016 Aug; 30(7):506-9. PubMed ID: 27221817
[TBL] [Abstract] [Full Text] [Related]